Golden State Equity Partners - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 69 filers reported holding CLEARSIDE BIOMEDICAL INC in Q4 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.

Quarter-by-quarter ownership
Golden State Equity Partners ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q2 2023$22,154
+7.7%
19,7800.0%0.01%
-45.5%
Q1 2023$20,571
-71.4%
19,780
-36.9%
0.01%
-69.4%
Q1 2022$72,000
-14.3%
31,327
+2.6%
0.04%
-14.3%
Q4 2021$84,00030,5270.04%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q4 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders